AI Consensus Index

Best OTC Hearing Aids for Seniors (2026)

Jabra Enhance Select 700 leads the September 2026 consensus ranking for Over-the-Counter Hearing Assistance, followed by ELEHEAR Beyond Pro and Sony CRE-C10.

Seven-platform comparisonA transparent comparison of which providers receive repeated recognition across seven AI platforms.
Built for careful comparisonSee the strengths, limitations, pricing considerations, and questions worth investigating before you decide.
Best OTC Hearing Aids for Seniors (2026) hero image
senior-technologyPublished by Aging in Place Index to support informed aging-in-place decisions.

Answer Capsule

Jabra Enhance Select 700 leads the September 2026 consensus ranking for Over-the-Counter Hearing Assistance, followed by ELEHEAR Beyond Pro and Sony CRE-C10. The current study includes 7 valid AI-platform responses and 10 qualifying entities. Compared with August 2026, the leader changed. The current list added Sony CRE-C10, Sennheiser All-Day Clear, Lucid Engage, MDHearing NEO XS, and Apple AirPods Pro 2 and removed Audicus Omni 2, Soundbright, Eargo 7, and Sennheiser All-Day Clear Slim. This is an immediately preceding-month comparison. Rank movement measures changes in this collection of standardized AI-platform responses. It is not product testing, customer-review evidence, or proof that a provider's underlying quality improved or declined.

What Changed Since August 2026

This comparison uses the immediately preceding completed month.

Jabra Enhance Select 700 remained No. 1 in September 2026. It was named by 7 platforms, compared with 5 in August 2026. Both studies used 7 valid platform responses.

The largest upward moves were ELEHEAR Beyond Pro (up 3) and Jabra Enhance Select 700 (up 1). The largest downward moves were Audien Atom Pro 2 (down 6), Lexie B2 Plus Powered by Bose (down 5), and Yeasound RIC800 (down 3).

The current qualifying set added Sony CRE-C10, Sennheiser All-Day Clear, Lucid Engage, MDHearing NEO XS, and Apple AirPods Pro 2. It no longer includes Audicus Omni 2, Soundbright, Eargo 7, and Sennheiser All-Day Clear Slim from the earlier top group. Entry or exit reflects the minimum-mention rule and the current response set, not a product launch, discontinuation, or quality finding.

Current rankEntityPrevious rankRank movementCurrent mentionsPrevious mentionsMention change
1Jabra Enhance Select 7002Up 175+2
2ELEHEAR Beyond Pro5Up 362+4
3Sony CRE-C10—New6——
4Sennheiser All-Day Clear—New5——
5Lucid Engage—New4——
6MDHearing NEO XS—New4——
7Audien Atom Pro 21Down 646-2
8Lexie B2 Plus Powered by Bose3Down 533+0
9Yeasound RIC8006Down 322+0
10Apple AirPods Pro 2—New2——
—Audicus Omni 24Exited—3—
—Soundbright7Exited—2—
—Eargo 78Exited—2—
—Sennheiser All-Day Clear Slim9Exited—2—

The table is calculated directly from the two stored ranking datasets. Positive rank movement means an entity moved closer to No. 1; mention change shows the difference in the number of included platform responses naming it.

The August 2026 edition preserves the complete earlier ranking and methodology for reference.

Research Snapshot

  • Topic: Best OTC hearing aids for seniors (over-the-counter hearing assistance)
  • Target buyer: Adults with perceived mild-to-moderate hearing loss who want a lower-cost hearing aid option without an in-person prescription fitting
  • Geography: United States
  • Platforms included (7): OpenAI, Anthropic, DeepSeek, Grok, Perplexity, Kimi, Google
  • Research date: 2026-09-27
  • Unique entities named: 18
  • Qualifying entities: 10
  • Eligibility rule: Named by at least two platforms during ranking discovery
  • Ranking rule: Platform mentions, then average listed rank, then best listed rank
  • Study design: One standardized prompt sent once to each included platform

Platform mentions count only ranking-discovery mentions. Several platforms later completed fit assessments for entities they did not name during ranking discovery; those assessments inform the evidence bundles but do not change mention counts. Platform-reported research dates differ from the authoritative run date of 2026-09-27 and are provenance metadata only.

The Consensus Ranking

Questions This Section Answers

  • What are the best OTC hearing aids for seniors with mild-to-moderate hearing loss in 2026?
  • Which OTC hearing aid did the most AI platforms recommend, and how often was each option named?

The table below is the sole authority for rank, platform mentions, platform share, average listed position, and best listed position. It is reproduced exactly as calculated and is not recalculated here.

Note the structural tension in this table: Lexie B2 Plus Powered by Bose has the second-best average listed position (2.00) and a best position of 1, but only three platforms named it, so it ranks eighth. Yeasound RIC800 has the third-best average listed position (3.50) but only two mentions, so it ranks ninth. Rank order here reflects breadth of platform agreement first, not average placement alone.

RankEntityPlatform mentionsAverage listed positionBest positionBest considered for
1Jabra Enhance Select 70071.431Adults with perceived mild-to-moderate hearing loss who are comfortable using a smartphone; Buyers wanting rechargeable hearing aids with remote professional support; Buyers who value a lengthy trial period and ongoing remote adjustments
2ELEHEAR Beyond Pro62.51Buyers wanting self-directed OTC setup with optional remote audiologist assistance; Users who value Bluetooth calling and music streaming, app-based presets, noise controls, and rechargeable operation; Buyers seeking a mid-priced option with a 45-day direct-purchase trial
3Sony CRE-C1064.53Conversation-focused users who want an almost invisible in-canal device.; Buyers comfortable following smartphone-app setup instructions and changing disposable batteries.; Adults seeking a self-fitting OTC option below many traditional prescription-aid prices.
4Sennheiser All-Day Clear55.22Adults seeking a higher-end OTC receiver-in-canal pair without an in-person prescription fitting; Users who value Bluetooth streaming and hands-free calling on iPhone or Android; Buyers comfortable completing app-based setup and sound-profile testing
5Lucid Engage46.754Adults wanting rechargeable OTC hearing aids without a prescription or in-person fitting.; Buyers who value app-controlled sound customization and Bluetooth streaming.; Seniors who may benefit from Lucid's stated lifetime access to licensed specialists and audiologists.
6MDHearing NEO XS46.754Adults with perceived mild-to-moderate hearing loss who prioritize low upfront cost and no prescription or clinic visit.; Seniors who prefer physical controls, a small in-ear design, rechargeable operation, and telephone or video support.; Buyers who want a meaningful trial period and access to setup help without paying separately for an office fitting.
7Audien Atom Pro 247.06Adults with perceived mild hearing loss who prioritize low price, physical controls, rechargeable operation, and minimal technology.; Buyers mainly needing basic amplification in relatively quiet settings who are willing to test fit and sound during the return period.; Tech-shy seniors who prefer button controls over app setup
8Lexie B2 Plus Powered by Bose32.01Adults 18 or older with perceived mild-to-moderate hearing loss who want to purchase and configure hearing aids without a prescription or clinic fitting.; Buyers who value rechargeable hardware, app-based hearing testing, multiple listening environments, and phone-call streaming.; Seniors who can use a smartphone or have a caregiver available for app setup and ongoing adjustments.
9Yeasound RIC80023.53Adults with perceived mild-to-moderate loss who want a discreet rechargeable RIC design.; Buyers who value Bluetooth calls and music on both iOS and Android.; Buyers prioritizing measured speech-in-quiet, feedback handling, and streaming performance at a sub-$1,000 price.
10Apple AirPods Pro 226.55iPhone users seeking a relatively low-cost, dual-purpose OTC hearing device; Adults comfortable completing a hearing test and setup through an iPhone or iPad; Users who value adjustable amplification, tone, balance, Transparency mode, and ordinary wireless-earbud functions

Which Option Is Best for Which Version of the Buyer Need?

Questions This Section Answers

  • Which OTC hearing aid should a senior choose if they need the longest trial period and remote professional support?
  • Is ELEHEAR Beyond Pro or Jabra Enhance Select 700 better for a buyer who wants strong speech-in-noise performance under $700?
  • Which OTC hearing aid is best for a senior who wants no smartphone app at all?
Buyer needBest-ranked matchWhy, per evidence bundlesKey tradeoff to verify
Longest trial plus remote professional supportJabra Enhance Select 700 (rank 1)100-day direct-purchase return period; 3 years of remote audiology care bundled in the price; 24+ hour battery [e1:anthropic:c1]Premium price ($1,695–$1,995 reported); weak speech-in-noise lab score (1.0/5) [e1:anthropic:c5]
Best measured speech-in-noise value under $700ELEHEAR Beyond Pro (rank 2)$599/pair; HearAdvisor A SoundGrade with 3.6 speech-in-noise score; 20-hour battery; 45-day trial [e2:anthropic:hearingtracker1]Larger RIC body; mixed comfort reports; no telecoil or Auracast [e2:anthropic:hearingtracker1]
Almost invisible in-canal fitSony CRE-C10 (rank 3)Completely-in-canal design; Grade A / 4.2 SoundScore; up to 70 hours per disposable battery [e3:google:1.1.1]Discontinued May 2026; no Bluetooth streaming; disposable size-10 batteries [e3:google:3.1.2]
Bluetooth streaming plus optional in-clinic upgradeSennheiser All-Day Clear (rank 4)Bluetooth calls.
Watch Watch the video on YouTube on YouTube

1. Jabra Enhance Select 700

Questions This Section Answers

  • Is Jabra Enhance Select 700 worth it for seniors with mild-to-moderate hearing loss, and what are its main drawbacks?
  • Which OTC hearing aid has the longest trial period and included remote audiology support?

Verdict. The Jabra Enhance Select 700 is the only entity named by all seven platforms, and the evidence bundles describe it as a premium, support-heavy OTC package rather than a budget device. It pairs a micro receiver-in-ear design with a 100-day direct-purchase return period, a stated 3-year audiology support window, and a 24+ hour rechargeable battery [e1:anthropic:c1]. The central caveat is that the model appears to be transitioning to the Select M3 successor, and current pricing, availability, and self-fitting documentation are not consistent across sources [e1:openai:c8].

Why it ranked here. Seven of seven platforms named it, with ranks ranging from 1 to 2 across platforms [e1:openai:c1][e1:anthropic:c1][e1:deepseek:C1][e1:grok:0][e1:perplexity:c1][e1:kimi:ncoa-hearing-aids][e1:google:1.1.4]. No other entity achieved full platform coverage. Its average listed position of 1.43 is the best in the study.

Best suited for. Smartphone-comfortable adults who want remote professional adjustments, a long trial, and a discreet rechargeable RIC design. It is a weaker fit for buyers seeking the lowest-cost OTC option or who lack a compatible smartphone or tablet [e1:openai:c1].

Main strengths for this use case. FDA-cleared self-fitting test in the app with four preset environmental modes; independent reviewers called setup "one of the simplest OTC hearing aids tested" [e1:anthropic:c7]. Battery: 24 hours typical, up to 30 hours maximum, with a charging case holding three additional charges [e1:anthropic:c1]. Feedback handling scored 5.0/5 and own-voice comfort 3.7/5 in independent lab testing [e1:anthropic:c5]. IP68 water and dust rating; Bluetooth LE Audio and Auracast ready [e1:anthropic:c3].

Main limitations. Speech-in-noise scored 1.0/5 in independent lab testing, 0.48 points below the 1.48 category average [e1:anthropic:c5]. No telecoil and no CROS option; rechargeable-only with no disposable battery variant [e1:anthropic:c4]. Music streaming quality was rated mixed at 2.5/5 [e1:anthropic:c5]. One platform reported the model ranks #26 of 65 OTC hearing aids tested, in the top 38% [e1:anthropic:c5].

Pricing or cost summary. Reported prices conflict: $1,995 list with a $1,695 promotional price [e1:anthropic:c1], $1,795 in one lab citation [e1:anthropic:c5], and $1,695–$1,995 across company and review pages [e1:perplexity:c1].

What Changed Since August 2026

Jabra Enhance Select 700 moved up from No. 2 to No. 1, and platform mentions increased from 5 to 7. The September 2026 article recasts Jabra Enhance Select 700 as a premium, support-heavy OTC package that may be transitioning to the Select M3 successor, rather than the earlier framing that emphasized its discreet design and ranking position. The prior write-up detailed bundle extras (three-year warranty with loss-and-damage protection and a 100-day trial); the current section instead highlights a stated three-year audiology support window, a 30-hour maximum battery figure, and a 100-day return period. Pricing evidence shifted: the earlier $1,695 to $1,995 range, $1,500 ceiling comparison, and $195 deductible are no longer repeated, while the current article reports conflicting figures without a settled range. The limitations discussion also now foregrounds a below-average speech-in-noise score. Differences between the two editions reflect what each article reports; they do not by themselves prove that the product, service, or price changed.

2. ELEHEAR Beyond Pro

Questions This Section Answers

  • Is ELEHEAR Beyond Pro worth it for a senior who wants strong speech-in-noise performance under $700?
  • What are the main drawbacks of ELEHEAR Beyond Pro for adults with mild-to-moderate hearing loss?

Verdict. ELEHEAR Beyond Pro is the value-oriented counterweight to the Jabra package: $599 per pair, an A SoundGrade from independent lab testing, and a 45-day trial, but with a larger RIC body, mixed comfort reports, and no telecoil or Auracast [e2:anthropic:hearingtracker1]. Six of seven platforms named it, and one platform ranked it first overall [e2:openai:c9].

Why it ranked here. Six platform mentions at an average listed position of 2.50, with a best position of 1. Ranks by platform ranged from 1 to 5 [e2:openai:c9][e2:anthropic:hearingtracker1][e2:deepseek:C1][e2:grok:web:0][e2:perplexity:c1][e2:kimi:elehear-product].

Best suited for. Buyers who want self-directed setup with optional remote audiologist review, Bluetooth calling and music streaming, app-based presets, and a mid-priced pair with a 45-day direct-purchase trial [e2:openai:c9].

Main strengths for this use case. Independent lab testing awarded an A SoundGrade with a 3.6 speech-in-noise score and 5.0 feedback handling [e2:anthropic:hearingtracker1]. Battery: up to 20 hours per charge with roughly four additional case charges; a 15-minute quick charge yields about 6 hours [e2:anthropic:hearingtracker1]. Bluetooth 5.3 with hands-free calling on iOS and Android; extended frequency range of 125 Hz–8,500 Hz [e2:anthropic:elehear_blog_review]. Tinnitus masking with 20+ soundscapes [e2:anthropic:elehear_product]. Lifetime telehealth support via Elehear Pro was reported [e2:anthropic:hearingtracker1].

Main limitations. Multiple independent reviewers reported scratchy hiss and static above moderate volume settings, and one noted excessive static above level 4 on a 19-step scale [e2:anthropic:wired1]. Comfort was mixed: one reviewer reported discomfort after 2+ hours, particularly with glasses, and the behind-ear component moved during head motion [e2:anthropic:wired1]. Consumer Reports listed the model as not water resistant while the company specifies IPX5, a direct conflict [e2:openai:c3]. No telecoil and no Auracast support [e2:anthropic:hearingtracker1]. Own-voice score was low at 1.2, suggesting a boomy closed-dome effect [e2:anthropic:hearingtracker1].

Pricing or cost summary. $599 per pair on the direct product page, with a Beyond Pro plus dry-box bundle at approximately $631 [e2:openai:c9]. One source cited $649 as a regular price with $599 promotional pricing [e2:anthropic:elehear_product]. Consumer Reports estimated approximately $93 in annual replacement-accessory costs [e2:openai:c3]. Warranty was reported as approximately 12 months [e2:openai:c9]. HSA/FSA eligibility was noted [e2:grok:web:0].

What Changed Since August 2026

ELEHEAR Beyond Pro moved up from No. 5 to No. 2, and platform mentions increased from 2 to 6. The September 2026 article recasts ELEHEAR Beyond Pro as the value-oriented alternative to the Jabra package, dropping the earlier smartphone-dependency framing that dominated the August 2026 verdict. Buyers now get a clearer fit profile: self-directed setup with optional remote audiologist review, plus a 45-day trial. The current article reports $599 per pair and a $649 regular price, while the $399–$599 range the earlier write-up gave is no longer repeated. Warranty is now stated as approximately 12 months, whereas the earlier section mentioned a 15-hour figure that the current one does not repeat. Limitations are expanded, including a larger RIC body and no telecoil or Auracast. Differences between the two editions reflect what each article reports; they do not by themselves prove that the product, service, or price changed.

3. Sony CRE-C10

Questions This Section Answers

  • Is Sony CRE-C10 worth it for a senior who wants an invisible in-canal OTC hearing aid in 2026?
  • What should a buyer check before purchasing a discontinued OTC hearing aid like the Sony CRE-C10?

Verdict. The Sony CRE-C10 delivers some of the strongest measured acoustics in this index — a Grade A and 4.2/5 SoundScore from independent lab testing, ranking in the top 17% of OTC hearing aids tested [e3:google:1.1.1] — inside a completely-in-canal design that reviewers described as virtually invisible [e3:google:1.1.5]. The decisive problem is availability: Sony officially discontinued sales of its entire OTC hearing aid lineup, including the CRE-C10, on May 26, 2026, while Sony and WS Audiology continue to honor post-purchase support and warranty obligations [e3:google:3.1.2][e3:google:3.1.3].

Why it ranked here. Six platform mentions at an average listed position of 4.50, with a best position of 3. Ranks ranged from 3 to 6 [e3:openai:c1][e3:anthropic:sony_electronics_faq][e3:deepseek:sony-hearing][e3:grok:0][e3:perplexity:c1][e3:kimi:ncoa-2026].

Best suited for. Conversation-focused users who want an almost invisible in-canal device, buyers comfortable following app setup instructions and changing disposable batteries, and adults seeking a self-fitting OTC option below many prescription-aid prices [e3:openai:c1].

Main strengths for this use case. Independent lab results: 4.5/5 speech in quiet and 2.9/5 speech in noise, both above that laboratory's category averages [e3:openai:c4]. Up to 70 hours of continuous use per size-10 disposable battery, with reviewers confirming roughly 68–70 hours [e3:anthropic:wired_c10_review]. Four replaceable ear tip sizes with a vented design to reduce occlusion [e3:anthropic:hearing_health_matters_review]. Sony advertises a 45-day return benefit and a free one-to-one virtual consultation with OTC hearing-aid experts [e3:openai:c1].

Main limitations. No Bluetooth or Wi-Fi audio streaming; independent lab testing scored streaming performance 0.0/5 [e3:openai:c4]. Disposable size-10 batteries create recurring cost and require opening the battery compartment to power off [e3:anthropic:wired_c10_review]. Setup can be error-prone: an incorrectly muted phone media volume prevented initial communication with the aids in one independent review [e3:openai:c3]. Feedback handling was below category average and own-voice comfort was mixed [e3:openai:c4]. The tiny size can be difficult to handle for users with limited dexterity [e3:google:2.2.9].

Pricing or cost summary. Sony's official product page listed $699.99 while also stating the item is no longer available [e3:openai:c1]. Earlier sources cited $999.99 MSRP, and one retailer range was reported at $700–$1,100 [e3:anthropic:hearingtracker_sony].

4. Sennheiser All-Day Clear

Questions This Section Answers

  • Is Sennheiser All-Day Clear worth it for a senior who wants Bluetooth streaming and an optional in-clinic fitting upgrade?
  • Which OTC hearing aid under $1,000 offers the strongest speech clarity in quiet environments?

Verdict. Sennheiser All-Day Clear is a mid-to-premium RIC pair with Bluetooth streaming, hands-free calling, and an optional paid In-Clinic Care Package that lets buyers add professional fitting later [e4:openai:c1]. Independent lab testing ranked it #6 among 65 tested OTC devices with a 4.4/5 SoundScore and A grade, placing it in the top 8% of the category [e4:anthropic:c6]. Its main weaknesses are a higher price, a charger that must remain connected to power, and weak speech-in-noise performance.

Why it ranked here. Five platform mentions at an average listed position of 5.20, with a best position of 2. Ranks ranged from 2 to 8 [e4:openai:c1][e4:anthropic:c1][e4:deepseek:cite-1][e4:grok:0][e4:perplexity:1].

Best suited for. Adults seeking a higher-end OTC receiver-in-canal pair without an in-person prescription fitting, users who value Bluetooth streaming and hands-free calling on iPhone or Android, and buyers comfortable completing app-based setup and sound-profile testing [e4:openai:c1].

Main strengths for this use case. App-guided self-fitting takes approximately 5 minutes, with seven volume choices and six clarity choices [e4:anthropic:c2]. Independent lab scores: 4.0/5 speech clarity in quiet, 3.3/5 music streaming, and 5.0/5 feedback handling [e4:anthropic:c6]. IP68 rating for moisture and dust resistance [e4:anthropic:c4]. Bluetooth A2DP streaming and HFP hands-free calling, pairing to up to two devices [e4:anthropic:c4]. Optional In-Clinic Care Package adds in-person consultation, professional fitting, and a second warranty year [e4:anthropic:c4].

Main limitations. Speech in noise scored 1.9/5 — above the 1.51 category average but low in absolute terms [e4:anthropic:c6]. The standard charger uses micro-USB and must be connected to power; the case does not provide independent on-the-go charging [e4:openai:c1]. No telecoil and no Auracast [e4:perplexity:4]. One independent reviewer reported substantial background hiss, difficult positioning, and poor perceived benefit in an individual test [e4:openai:c4]. Sold only as a pair, which may be unnecessary for unilateral hearing loss [e4:openai:c1].

Pricing or cost summary. The official product page listed $999.95 per pair with free shipping and a one-year manufacturer warranty [e4:openai:c7]. One source cited $799.95 promotional and $999.95 regular pricing [e4:anthropic:c1], and a retailer listed $949.95 [e4:anthropic:c4]. Extended warranties were reported at approximately $27 (1-year), $54 (2-year), and $82 (3-year) [e4:anthropic:c4].

5. Lucid Engage

Questions This Section Answers

  • Is Lucid Engage worth it for a senior who wants manual frequency-level sound tuning in an OTC hearing aid?
  • Which OTC hearing aid has the best speech clarity in quiet environments but weak feedback handling?

Verdict. Lucid Engage is a mid-priced RIC pair whose distinguishing feature is LucidShape, an app control that lets users adjust sound frequencies in real time rather than relying only on presets [e5:google:1.2.1]. Independent lab testing awarded an A grade and 4.2/5 SoundScore with 4.3/5 speech clarity in quiet, but feedback handling scored 2.6/5 — nearly two points below the 4.54 category average [e5:anthropic:C11].

Why it ranked here. Four platform mentions at an average listed position of 6.75, with a best position of 4. Ranks ranged from 4 to 10 [e5:openai:c1][e5:anthropic:C1][e5:deepseek:C1][e5:perplexity:c1].

Best suited for. Adults wanting rechargeable OTC hearing aids without a prescription or in-person fitting, buyers who value app-controlled sound customization and Bluetooth streaming, and seniors who may benefit from Lucid's stated lifetime access to licensed specialists and audiologists [e5:openai:c1].

Main strengths for this use case. Four pre-programmed hearing profiles developed from machine learning on millions of audiograms, claimed to support up to 92% of mild-to-moderate hearing losses [e5:anthropic:C4]. Rechargeable model provides approximately 16 hours per charge with an included charging case [e5:anthropic:C7]. Nine pairs of assorted ear tips included for fit customization [e5:anthropic:C8]. Support available via chat, email, and phone Monday–Saturday, 8am–6pm CST, with licensed specialists at 500+ Lucid Hearing centers [e5:anthropic:C3].

Main limitations. Feedback handling scored 2.6/5, nearly two points below the category average, which may produce whistling in certain conditions [e5:anthropic:C11]. Music streaming quality was mixed at 2.4/5 [e5:anthropic:C11]. The reviewed evidence does not clearly establish that Engage performs a complete FDA-style self-fitting hearing test rather than app-based adjustment [e5:openai:c1]. Requires a compatible smartphone with Bluetooth; excludes users without mobile devices or comfort with app-based control [e5:anthropic:C1]. Return windows vary by retailer from 30 to 90 days [e5:anthropic:C5][e5:anthropic:C6].

Pricing or cost summary. Lucid listed Engage Rechargeable at $849.99 and the non-rechargeable Engage at $649.99 [e5:openai:c6]. One source reported a 40% promotional discount bringing the rechargeable model to $509.99 and the standard model to $389.99 during a March 27–29, 2026 promotion [e5:anthropic:C9]. Another independent source cited approximately $700 for the rechargeable model [e5:anthropic:C10].

6. MDHearing NEO XS

Questions This Section Answers

  • Is MDHearing NEO XS worth it for a senior who wants the lowest-cost rechargeable OTC hearing aid with no app?
  • Which OTC hearing aid under $400 has the best feedback handling but the weakest speech clarity?

Verdict. MDHearing NEO XS is the budget-and-discretion play: a completely-in-canal design priced at $297–$397 per pair with 18+ hours of battery life, four preset programs via a physical button, and a 60-day trial [e6:anthropic:1]. Independent lab testing awarded a Grade C and 2.9/5 SoundScore, ranking #63 of 65 OTC devices tested, with speech clarity in quiet at 1.0/5 — 1.77 points below the category average [e6:anthropic:3]. Feedback handling, by contrast, scored 5.0/5 [e6:anthropic:3].

Why it ranked here. Four platform mentions at an average listed position of 6.75, with a best position of 4. Ranks ranged from 4 to 9 [e6:openai:c1][e6:anthropic:1][e6:deepseek:c1][e6:perplexity:c1].

Best suited for. Adults with perceived mild-to-moderate hearing loss who prioritize low upfront cost and no prescription or clinic visit, seniors who prefer physical controls and a small in-ear design, and buyers who want a meaningful trial period with access to setup help [e6:openai:c1].

Main strengths for this use case. Lowest cost entry point among the CIC options in this index at $297–$397 promotional pricing [e6:anthropic:1]. Excellent feedback handling at 5.0/5, above the 4.54 category average [e6:anthropic:3]. 18+ hours per charge with a portable case providing six additional full charges, roughly 100 hours total [e6:anthropic:1]. Free lifetime support from licensed hearing professionals by phone, text, web chat, email, and video chat [e6:openai:c1]. No app required, which simplifies operation for tech-averse seniors [e6:anthropic:6].

Main limitations. Speech clarity in quiet and in noise both scored 1.0/5 in independent lab testing [e6:anthropic:3]. Not water resistant; moisture and oil should be wiped away before charging [e6:anthropic:2]. No app, no Bluetooth streaming, no telecoil, and no wireless synchronization between left and right ears [e6:anthropic:2]. The tiny button placement makes unintended volume adjustment likely during insertion [e6:anthropic:6]. The built-in rechargeable battery is not user-replaceable [e6:openai:c3].

Pricing or cost summary. The checked product page listed the pair at $297 with a displayed promotional price of $252.45 [e6:openai:c2]. Other sources cited $397 per pair [e6:anthropic:1][e6:google:cite_hearingtracker].

7. Audien Atom Pro 2

Questions This Section Answers

  • Is Audien Atom Pro 2 worth it for a tech-shy senior who wants no app and no Bluetooth?
  • Which OTC hearing aid under $300 has the weakest speech-in-noise performance?

Verdict. Audien Atom Pro 2 is the simplest device in this index: $289 per pair, no app, no Bluetooth, four preset listening modes and five volume levels controlled by a single physical button, plus a UV-sanitizing charging case [e7:openai:C1]. Every platform that assessed fit rated it "mixed" — the only entity in this index with unanimous mixed ratings [e7:openai:C1][e7:anthropic:c1][e7:deepseek:C1][e7:grok:0][e7:perplexity:c1][e7:kimi:c2][e7:google:1.1.2].

Why it ranked here. Four platform mentions at an average listed position of 7.00, with a best position of 6. Ranks ranged from 6 to 8 [e7:openai:C1][e7:anthropic:c1][e7:deepseek:C1][e7:perplexity:c1].

Best suited for. Adults with perceived mild hearing loss who prioritize low price, physical controls, rechargeable operation, and minimal technology, plus tech-shy seniors who prefer button controls over app setup [e7:openai:C1].

Main strengths for this use case. $289 per pair, among the lowest prices in this index [e7:openai:C1]. No prescription, in-person fitting, app, or smartphone skills required [e7:openai:C1]. Approximately 24 hours of battery life with a charging case that includes UV sterilization [e7:anthropic:c4]. Excellent feedback handling at 5.0/5 in independent lab testing [e7:google:1.2.2]. 45-day money-back guarantee [e7:openai:C1].

Main limitations. Independent testing reported below-average speech performance in quiet and noise, with mechanical or mid-frequency-focused sound and only modest practical benefit in noisy environments [e7:openai:C3]. No IP ingress-protection rating was identified, and warranty exclusions include water exposure and wax buildup [e7:openai:C3]. No Bluetooth streaming and no app-based customization [e7:openai:C3]. Additional follow-up hearing-specialist appointments may cost $100 unless covered by AudienCare [e7:openai:C1]. One independent source reported an eardrum rupture from difficult device removal, though causation is unclear and only one report was available [e7:anthropic:c12].

Pricing or cost summary. $289 per pair on the official product page with free U.S. shipping [e7:openai:C1]. Independent pricing showed variation at approximately $264, $284, and $289 per pair depending on seller and date [e7:openai:C3]. AudienCare is a recurring subscription at $9.00 per month that automatically renews [e7:official:C2]. A protection plan with a reported ~$49 deductible was noted by one platform [e7:grok:6].

Where platforms disagreed. All seven platforms rated fit "mixed," but for different reasons.

What Changed Since August 2026

Audien Atom Pro 2 moved down from No. 1 to No. 7, and platform mentions decreased from 6 to 4. The September 2026 article recasts this device as the index's simplest option: the Audien Atom Pro 2 is now described as a $289-per-pair, no-app, no-Bluetooth aid with four preset listening modes, five volume levels, and a single physical button. That is a narrower buyer fit than the earlier write-up of the Audien ION Pro 2, which emphasized app-based customization, Bluetooth streaming, and directional microphones for tech-comfortable users. The current section newly reports $289 and adds $264 as an independent price, while the earlier $689 figure is not repeated. Battery reporting also shifts, from a claimed 48–72 hours to approximately 24 hours with the UV-sanitizing case. The 45-day money-back guarantee remains. Differences between the two editions reflect what each article reports; they do not by themselves prove that the product, service, or price changed.

8. Lexie B2 Plus Powered by Bose

Questions This Section Answers

  • Is Lexie B2 Plus Powered by Bose still worth buying in 2026 given the reported company wind-down?
  • Which OTC hearing aid has the best average platform ranking but the fewest platform mentions?

Verdict. Lexie B2 Plus Powered by Bose has the second-best average listed position in this entire index (2.00) and a best position of 1, yet it ranks eighth because only three platforms named it. The evidence bundles describe a capable self-fitting RIC pair with an in-app hearing test, up to 10 custom programs, and a 45-day trial [e8:anthropic:C1] — but also a reported wind-down of parent company LXE Hearing's U.S. operations and deactivation of the Lexie App's cloud connectivity on October 8, 2026 [e8:google:lxe_wind_down].

Why it ranked here. Three platform mentions at an average listed position of 2.00, with a best position of 1. Ranks by platform were 1, 2, and 3 [e8:anthropic:C1][e8:deepseek:c1][e8:openai:c1]. The low mention count, not the placement quality, drives the rank.

Best suited for. Adults 18 or older with perceived mild-to-moderate hearing loss who want to purchase and configure hearing aids without a prescription or clinic fitting, buyers who value rechargeable hardware and app-based hearing testing, and seniors who can use a smartphone or have a caregiver available for app setup [e8:openai:c1].

Main strengths for this use case. In-app hearing test using hearX diagnostic technology, with results producing a personalized profile [e8:anthropic:C3]. Up to 10 custom programs plus four standard environment presets [e8:anthropic:C1]. Battery: 16–18 hours per charge with the case holding one additional full charge, roughly 36 hours total [e8:anthropic:C1]. Free lifetime support from Lexie Experts via phone, video call, email, and in-app chat, with proactive outreach during the first 45 days [e8:anthropic:C5]. IP57 splash and dust resistance [e8:anthropic:C6].

Main limitations. Limited tuning depth: only two real mechanisms (world volume and a bass/treble slider) rather than frequency-specific customization [e8:anthropic:C2]. Bluetooth connectivity issues reported, including occasional disconnections and suboptimal call audio quality on some Android devices [e8:anthropic:C8]. Closed domes caused itchy ear canals after 1+ hours for some users, and fit retention issues were reported for smaller ear canals [e8:anthropic:C2]. No telecoil and no Auracast [e8:anthropic:C6]. The charging case was described as "quite chunky" in one independent review [e8:anthropic:C2].

Pricing or cost summary. $999 per pair on the official product page [e8:openai:c1].

What Changed Since August 2026

Lexie B2 Plus Powered by Bose moved down from No. 3 to No. 8, and platform mentions were unchanged at 3. The September 2026 article reframes the Lexie B2 Plus Powered by Bose around the reported LXE wind-down, including deactivation of the app's cloud connectivity on October 8, 2026, rather than around its lab-tested sound performance. The earlier write-up's pricing detail is no longer repeated, including $899 and $899–$999. Battery reporting shifted from a single 18-hour figure to 16–18 hours per charge, about 36 hours with the case, and the 45-day trial now doubles as a support-outreach window. Newly described limitations include shallow tuning depth and Bluetooth dropouts. The buyer-facing takeaway is a capable self-fitting device whose long-term support has become the decisive question. Differences between the two editions reflect what each article reports; they do not by themselves prove that the product, service, or price changed.

9. Yeasound RIC800

Questions This Section Answers

  • Is Yeasound RIC800 worth it for a senior who wants top lab-tested acoustics under $700?
  • Which OTC hearing aid has the strongest independent lab scores but the fewest platform mentions?

Verdict. Yeasound RIC800 has the strongest independent acoustic evidence in this index — a Grade A and 4.7/5 SoundScore, ranking in the top 2% of OTC hearing aids tested, with 4.4/5 speech in quiet, 4.3/5 music streaming, and 5.0/5 feedback handling [e9:anthropic:c4] — at a $549–$699 price. It ranks ninth only because two platforms named it. The evidence bundles also document meaningful friction: no audiogram import, app/Bluetooth disconnect complaints, and a return-window conflict between 100 days and 45 days [e9:openai:c3][e9:perplexity:c2].

Why it ranked here. Two platform mentions at an average listed position of 3.50, with a best position of 3. Ranks by platform were 3 and 4 [e9:grok:2][e9:anthropic:c1]. The third-best average placement in the study is offset by the lowest mention count among the top nine.

Best suited for. Adults with perceived mild-to-moderate loss who want a discreet rechargeable RIC design, buyers who value Bluetooth calls and music on both iOS and Android, and buyers prioritizing measured speech-in-quiet, feedback handling, and streaming performance at a sub-$1,000 price [e9:openai:c1].

Main strengths for this use case. Independent lab results place it in the top 2% of OTC hearing aids tested [e9:anthropic:c4]. IPX8 waterproof rating, designed without metal charging contacts to reduce rust and skin irritation risk [e9:anthropic:c1]. Dual-chip architecture with a dedicated Bluetooth chip supporting MFi (iOS) and ASHA (Android) streaming plus Auracast [e9:google:cit_yeasound_dual_chip]. Charging case provides approximately three full recharges, roughly 124 hours away from an outlet [e9:anthropic:c1]. Yeasound can accept audiograms via email and remotely program hearing aids, per one source [e9:anthropic:c1].

Main limitations. No direct audiogram import in the app; fitting relies on three default frequency response shapes rather than custom curves [e9:anthropic:c2]. One independent reviewer reported frequent app disconnects requiring three to four resets per day [e9:anthropic:c3]. Battery claims conflict sharply: Yeasound advertises up to 31 hours, the specification section lists 23 hours, and one independent test measured approximately 18 hours under mixed hearing and Bluetooth use [e9:openai:c3]. Own-voice perception scored 2.1/5, below the 2.51 category average [e9:anthropic:c4]. Speech in noise was 2.4/5 — above average but mixed in absolute terms [e9:anthropic:c4].

What Changed Since August 2026

Yeasound RIC800 moved down from No. 6 to No. 9, and platform mentions were unchanged at 2. The September 2026 article recasts Yeasound RIC800 around lab evidence rather than value: it now leads with top-tier independent acoustic scores at a $549–$699 price, a newly reported figure, while the earlier $529–$699 range is no longer repeated. The $1,000 figure is also newly reported, framing it as a sub-$1,000 option. The earlier write-up emphasized presets, a 31-hour battery, and a 100-day trial; the current section documents friction instead — no audiogram import, app disconnect complaints, and conflicting return windows of 100 days and 45 days, plus battery figures of 23 hours specified and roughly 18 hours measured. Buyer fit shifts from price-sensitive shoppers to those prioritizing measured speech-in-quiet and feedback handling. Differences between the two editions reflect what each article reports; they do not by themselves prove that the product, service, or price changed.

10. Apple AirPods Pro 2

Questions This Section Answers

  • Is Apple AirPods Pro 2 worth it as an OTC hearing aid for a senior with mild-to-moderate hearing loss?
  • Which OTC hearing option has the lowest upfront cost but the shortest battery life and return window?

Verdict. Apple AirPods Pro 2 with the FDA-authorized Hearing Aid Feature is the lowest-cost entry in this index at $249 hardware, with a self-administered 5-minute hearing test and adjustable amplification, tone, and balance [e10:openai:C1][e10:openai:C6]. It is also the most constrained: 6 hours of listening time per charge with Active Noise Cancellation enabled, iOS-only compatibility, a 14-day Apple return window, and independent measurements finding default output under-amplified relative to prescriptive targets for two standardized audiograms [e10:openai:C4][e10:deepseek:C4].

Why it ranked here. Two platform mentions at an average listed position of 6.50, with a best position of 5. Ranks by platform were 5 and 8 [e10:google:1.1.2][e10:perplexity:c1].

Best suited for. iPhone users seeking a relatively low-cost, dual-purpose OTC hearing device, adults comfortable completing a hearing test and setup through an iPhone or iPad, and users who value adjustable amplification, tone, balance, Transparency mode, and ordinary wireless-earbud functions [e10:openai:C1].

Main strengths for this use case. FDA authorized the Hearing Aid Feature on September 12, 2024 under the De Novo pathway as the first OTC hearing aid software [e10:anthropic:C1]. The FDA-reviewed study included 118 subjects and reported similar perceived benefit for self-fitting versus professional fitting of the same device, with comparable amplification and speech-in-noise measures [e10:openai:C1]. Independent lab testing scored 4.2/5 speech clarity in quiet, 4.4/5 music streaming, and 5.0/5 feedback handling [e10:anthropic:C5]. Dual-purpose functionality: hearing aid plus premium Bluetooth earbuds for music, calls, and streaming across the Apple ecosystem [e10:anthropic:C7]. Settings persist on the AirPods firmware after setup [e10:openai:C1].

Main limitations. Battery life is 6 hours with the Hearing Aid feature active, versus 26–28 hours for some dedicated OTC competitors [e10:anthropic:C3]. Consumer Reports found the device "was unable to meet FDA requirements for amplifying lower-pitched sounds" while exceeding requirements for higher-pitched sounds [e10:anthropic:C3]. Speech understanding in noisy environments scored 2.3/5 [e10:anthropic:C5]. Own-voice comfort scored 1.9/5, below the category average, meaning users may report a disembodied self-voice perception [e10:anthropic:C5]. Requires a compatible iPhone or iPad running iOS 18.1 or later; no Android compatibility [e10:deepseek:C1]. The Apple return window is 14 days, shorter than most dedicated OTC hearing aids [e10:deepseek:C4].

What the Cross-Platform Study Reveals About This Market

Questions This Section Answers

  • What does the cross-platform AI consensus reveal about the OTC hearing aid market for seniors in 2026?
  • Which OTC hearing aid features do AI platforms consistently treat as decision-critical?

Four patterns emerge from the ten entity evidence bundles.

First, support and trial length function as the primary differentiator at the top of the ranking. The rank-1 entity bundles a 100-day return period and a stated 3-year audiology support window into the purchase price [e1:anthropic:c1]. The rank-2 entity offers a 45-day trial with lifetime telehealth support [e2:anthropic:hearingtracker1]. The rank-3 entity advertises a 45-day return benefit [e3:openai:c1]. Trial length and support access appear in nearly every "best considered for" field across the ranking table.

Second, price and measured performance are only loosely correlated in this index. The rank-1 entity carries the highest reported price ($1,695–$1,995) and the weakest speech-in-noise lab score (1.0/5) [e1:anthropic:c5]. The rank-9 entity carries a mid-range price ($549–$699) and the strongest overall lab score (4.7/5, top 2%) [e9:anthropic:c4]. The rank-10 entity carries the lowest price ($249) and a 6-hour battery [e10:anthropic:C3]. Buyers who assume price tracks performance will be surprised by this distribution.

Where the AI Platforms Agreed

Questions This Section Answers

  • On which OTC hearing aid attributes did all seven AI platforms agree?

Jabra Enhance Select 700 belongs at or near the top. All seven platforms named it, and no platform ranked it lower than 2 [e1:openai:c1][e1:anthropic:c1][e1:deepseek:C1][e1:grok:0][e1:perplexity:c1][e1:kimi:ncoa-hearing-aids][e1:google:1.1.4]. This is the only unanimous top-two placement in the study.

Rechargeable operation is now the default expectation. Every entity in the top seven except Sony CRE-C10 uses a rechargeable battery, and CRE-C10's disposable-battery design is consistently flagged as a limitation rather than a feature [e3:openai:c1][e3:anthropic:wired_c10_review].

Smartphone app dependence is a shared friction point. Platforms repeatedly noted that app-based setup, Bluetooth pairing, and account creation create barriers for some older adults, even when the app itself is well designed [e1:openai:c1][e4:openai:c1][e8:openai:c1][e10:openai:C1].

Speech-in-noise performance is weak across the category. Lab scores for speech in noise clustered in the low-to-mid range: 1.0/5 for the rank-1 entity [e1:anthropic:c5], 1.9/5 for rank 4 [e4:anthropic:c6], 2.3/5 for rank 10 [e10:anthropic:C5], and 2.4/5 for ranks 5 and 9 [e5:anthropic:C11][e9:anthropic:c4].

Where the AI Platforms Disagreed

Questions This Section Answers

  • Where did the AI platforms disagree about the best OTC hearing aids for seniors, and what should buyers verify as a result?

Fit ratings diverged sharply for several entities. Audien Atom Pro 2 received "mixed" from all seven platforms — the only unanimous mixed rating [e7:openai:C1][e7:anthropic:c1][e7:deepseek:C1][e7:grok:0][e7:perplexity:c1][e7:kimi:c2][e7:google:1.1.2]. Lexie B2 Plus Powered by Bose split between "good" (four platforms) and "weak" (two platforms), with the disagreement driven almost entirely by the reported company wind-down [e8:openai:c1][e8:google:lxe_wind_down]. Yeasound RIC800 split between "strong," "good," "mixed," and "uncertain" across five platforms [e9:grok:2][e9:anthropic:c1][e9:openai:c1][e9:deepseek:yeasound-site].

Pricing conflicts are pervasive. Jabra Enhance Select 700 was reported at $1,695, $1,795, and $1,995 across sources [e1:anthropic:c1][e1:anthropic:c5][e1:perplexity:c1]. Sennheiser All-Day Clear was reported at $799.95, $949.95, and $999.95 [e4:anthropic:c1][e4:anthropic:c4][e4:openai:c7]. MDHearing NEO XS was reported at $252.45, $297, and $397 [e6:openai:c2][e6:anthropic:1][e6:google:cite_hearingtracker]. Yeasound RIC800 was reported at $549, $599, $699, and $799 [e9:openai:c4][e9:openai:c3][e9:google:cit_hearingtracker_review].

How Buyers Should Choose

Questions This Section Answers

  • How should a senior with mild-to-moderate hearing loss choose between the top-ranked OTC hearing aids?
  • What should a buyer verify before purchasing any OTC hearing aid from this ranking?

Start with the constraint that eliminates the most options. If the buyer does not own a compatible iPhone or iPad, Apple AirPods Pro 2 is off the table [e10:deepseek:C1]. If the buyer cannot tolerate a smartphone app at all, the realistic shortlist narrows to MDHearing NEO XS and Audien Atom Pro 2 [e6:anthropic:6][e7:openai:C1]. If the buyer needs Bluetooth streaming, Sony CRE-C10 and Audien Atom Pro 2 are excluded [e3:openai:c4][e7:openai:C3].

Then weigh trial length against price. The rank-1 entity offers the longest reported trial at 100 days with bundled multi-year support at the highest reported price [e1:anthropic:c1]. The rank-2 entity offers 45 days at $599 with the strongest measured speech-in-noise value [e2:anthropic:hearingtracker1]. The rank-6 entity offers 60 days at $297–$397 with the weakest measured speech clarity [e6:anthropic:1][e6:anthropic:3]. Longer trials reduce the risk of a bad fit; shorter trials reduce the time to discover one.

Verify these items in writing before checkout, because the evidence conflicts. Exact out-the-door price including tax, shipping, and any protection plan.

Methodology

This index was produced from a single standardized prompt sent once to each of seven included AI platforms on 2026-09-27: OpenAI, Anthropic, DeepSeek, Grok, Perplexity, Kimi, and Google. Each platform was asked to identify and rank the best over-the-counter hearing assistance options for the defined buyer — adults with perceived mild-to-moderate hearing loss who want a lower-cost hearing aid option without an in-person prescription fitting, in the United States.

Eighteen unique entities were named across the seven platform responses. Ten qualified for the final ranking by being named by at least two platforms. The ranking order was calculated deterministically: platform mentions first, then average listed position, then best listed position. The final ranking table is the sole authority for rank, platform mentions, platform share, average listed position, and best listed position. No value in this article was recalculated.

Platform mentions count only ranking-discovery mentions. Several platforms completed fit assessments for entities they did not name during ranking discovery; those assessments inform the entity evidence bundles but do not change mention counts. Fit ratings, strengths, limitations, pricing, and disagreements in this article come from the entity evidence bundles, which consolidate platform-reported claims and citations.

Citation IDs are entity-namespaced and local to each entity bundle. A citation ID from one entity's bundle is never transferred to another entity.

Methodology Limitations

One prompt, one pass. The study used one standardized prompt sent once to each included platform. A different prompt wording, a different day, or a repeated run could produce different rankings.

AI answers are not stable. Platform answers can vary by date, wording, location, account state, model, interface, browsing configuration, and the sources retrieved. The rankings here describe one snapshot, not a permanent ordering.

Platform-reported research dates differ from the run date. Anthropic reported 2026-01-15 for most entities, DeepSeek reported 2026-01-15 or 2026-06-30 depending on entity, and the remaining platforms reported 2026-09-27. These dates are provenance metadata and do not independently prove freshness. Some pricing and availability details may reflect earlier states.

Platform recommendations are market intelligence, not independent customer reviews or proof of quality. A high rank means multiple AI platforms named the entity, not that the entity has been independently validated as superior.

Citations are platform-reported evidence, not independently verified facts. The URLs were collected from platform responses and were not independently validated by the writer stage. No-search model claims require explicit verification before being described as current facts.

Some entities have uncertainty about the contracting entity or availability questions. Sony CRE-C10's official site retrieval failed and the product is discontinued [e3:kimi:audiology-guide-2022][e3:google:3.1.2].

Final Verdict

Jabra Enhance Select 700 is the consensus leader of this 7-platform study, named by every included platform at an average listed position of 1.43. Its case rests on breadth of agreement plus a support-and-trial package — 100-day return, stated 3-year audiology support, 24+ hour battery — that no other entity matches [e1:anthropic:c1]. Its case is weakened by a premium price, a weak speech-in-noise lab score, and an unresolved model transition to the Select M3 [e1:anthropic:c5][e1:openai:c8].

ELEHEAR Beyond Pro is the strongest value alternative at $599 with an A SoundGrade and 3.6 speech-in-noise score [e2:anthropic:hearingtracker1]. Sony CRE-C10 offers the best combination of measured acoustics and invisibility, but only for buyers who can find remaining stock and accept disposable batteries and no streaming [e3:google:1.1.1][e3:google:3.1.2]. Apple AirPods Pro 2 is the lowest-cost entry at $249 for iPhone owners, with the shortest battery life and return window in the index [e10:openai:C6][e10:anthropic:C3].

No entity in this index is best for every buyer. The right choice depends on which constraint the buyer can least afford to violate: price, trial length, streaming, app dependence, battery life, or long-term support availability.

Frequently Asked Questions

What is the best OTC hearing aid for seniors in 2026 according to this study?

Jabra Enhance Select 700 ranked first, named by all seven included platforms at an average listed position of 1.43. It leads on breadth of platform agreement, not on every performance measure.

How many platforms were studied?

Seven: OpenAI, Anthropic, DeepSeek, Grok, Perplexity, Kimi, and Google. One standardized prompt was sent once to each.

How many entities qualified for the ranking?

Ten of eighteen named entities qualified by being named by at least two platforms.

Why does Lexie B2 Plus Powered by Bose rank eighth when its average listed position is 2.00?

Rank order is determined by platform mentions first. Lexie was named by only three platforms, so it ranks below entities named by four or more, regardless of placement quality.

Which OTC hearing aid has the longest trial period?

Jabra Enhance Select 700 advertises a 100-day direct-purchase return period [e1:anthropic:c1]. Yeasound RIC800's official product page also states a 100-day no-reason return, but its support policy page states 45 days, a direct conflict [e9:perplexity:c1][e9:perplexity:c2].

Consolidated Sources

Company-Owned Sources

Independent Sources

Other Sources

Verify This Research

Review the study details behind this page or download the public machine-readable verification record.

Study date
September 27, 2026
Platforms analyzed
7
Source records
296
Candidates reviewed
18
Qualified finalists
10

Research trail and source mix

Configured platforms

openai, anthropic, deepseek, grok, perplexity, kimi, google

Source mix

164 independent · 126 company-owned · 6 unclear

Evidence support

244 direct · 47 partial

Important limitation

Exactly 7 platforms were included in this run: openai, anthropic, deepseek, grok, perplexity, kimi, google. The configured source value 7 is provenance only and must never be described as the number of platforms studied.

Source snapshot SHA-256 85ab2bc740f439ad6f7c33c5a76381bc6e5155859dcf47d6de93252b5afe10c8

Archived editions

Browse earlier published research snapshots for this article. The latest edition remains at the current URL.